REPROS THERAPEUTICS INC.·4

Apr 16, 12:22 PM ET

van As Andre MD, PhD 4

4 · REPROS THERAPEUTICS INC. · Filed Apr 16, 2009

Insider Transaction Report

Form 4
Period: 2009-04-14
van As Andre MD, PhD
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-04-14$6.47/sh+30,000$194,10030,000 total
    Exercise: $6.47Exp: 2019-04-14Common Stock (30,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    410
  • Common Stock

    10,000
Footnotes (2)
  • [F1]The option vests and becomes exercisable at a rate of 1/12th per quarter for a period of 3 years.
  • [F2]These shares are subject to stockholder approval of an increase in the number of authorized shares available for issuance under the Company's 2004 Stock Option Plan.

Documents

1 file
  • 4
    rrd239909.xmlPrimary

    STOCK OPTION GRANT